Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147588 | SCV000195037 | uncertain significance | Cornelia de Lange syndrome 3 | 2013-03-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312979 | SCV000848213 | likely benign | Inborn genetic diseases | 2016-11-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000876948 | SCV001246706 | likely benign | not provided | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000147588 | SCV001593363 | likely benign | Cornelia de Lange syndrome 3 | 2024-11-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003975167 | SCV004787355 | likely benign | SMC3-related disorder | 2019-03-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |